関連する実験動画
Updated: May 5, 2026

09:16
Oligopeptide Competition Assay for Phosphorylation Site Determination
Published on: May 18, 2017
7.8K
規制解除されたMYC発現はAMPK関連キナーゼ5への依存を誘発する
Lidan Liu1, Jannes Ulbrich, Judith Müller
1Theodor Boveri Institute, Biocenter, University of Würzburg, Am Hubland, 97074 Würzburg, Germany.
Nature
|March 31, 2012
まとめ
AMPK関連キナーゼ5 (ARK5) を標的にすることは,MYC駆動がんに対する新しい治療戦略を提供します. ARK5を阻害すると,代謝性ホメオスタシスが乱され,がん細胞死亡とマウスモデルでの生存期間が延長されます.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- メタボリック・レギュレーション
背景:
- 規制解除されたMYCオンコタンパク質は,多数のヒト腫瘍を誘発する.
- がん治療のためのMYCをターゲットにすることは,依然として困難です.
- MYCは細胞の成長,増殖,代謝に影響を与えます.
研究 の 目的:
- MYC主導のがん代謝と生存におけるARK5の役割を調査する.
- ARK5がMYC誘発性腫瘍の有効な治療標的であるかどうかを判断する.
主な方法:
- 腫瘍性MYCを持つヒトとネズミの細胞系を利用した.
- ARK5阻害が代謝性ホメオスタシスとアポトシスに及ぼす効果を調べた.
- MYC駆動性肝細胞癌マウスモデルでARK5の減少を評価した.
主要な成果:
- 腫瘍性MYCは,代謝性ホメオスタシスと生存のためにARK5への依存を誘発する.
- ARK5はAMPK,mTORC1のシグナル伝達,そしてミトコンドリアの機能を調節する.
- ARK5の阻害は,MYCを発現する細胞でATPの枯渇とアポトーシスを引き起こします.
- ARK5の枯渇は,MYC駆動の肝がんモデルにおける生存率を改善する.
結論:
- ARK5は,代謝性ホメオスタシスと,MYC駆動がんの生存に不可欠である.
- ARK5をターゲットにすると,細胞のエネルギーバランスが乱され,がん細胞を選択的に排除します.
- 細胞エネルギーホメオスタシスの抑制は,MYC駆動腫瘍に対する有望な治療戦略を示しています.
さらに関連する動画
関連する概念動画
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Interactions Between Signaling Pathways
4.7K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
4.7K
MAPK Signaling Cascades
7.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
7.3K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
cAMP-dependent Protein Kinase Pathways
7.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K

